Altrova Health (FRA:WF8) Tariff Resilience Score: 5/10 (As of Jun. 27, 2026)


What is Altrova Health Tariff Resilience Score?

Altrova Health FRA:WF8 Tariff Resilience Score is 5 as of Jun. 27, 2026. The stock has 3 warning signs investors should review. Among 1,694 Asset Management companies, Altrova Health ranks better than 68.71% on this metric.

Altrova Health has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Altrova Health has Safe Supply Streaming Co Ltd, involved in cannabis streaming, faces moderate tariff risks due to international supply chain dependencies. While it can leverage alternative suppliers, regulatory complexities and limited pricing power in emerging markets affect its resilience.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Altrova Health might have Average Resilient.

Altrova Health  (FRA:WF8) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Altrova Health Tariff Resilience Score Related Terms

FRA:WF8 vs BLK, BX, KKR: Tariff Resilience Score Comparison

For the Asset Management subindustry, Altrova Health's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Altrova Health Tariff Resilience Score vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Altrova Health's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Altrova Health's Tariff Resilience Score falls into.


What does a Tariff Resilience Score of 5 mean?
Altrova Health (FRA:WF8) has a Tariff Resilience Score of 5 as of Jun. 27, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Altrova Health ranks #530 out of 1694 companies in the Asset Management industry, placing it in the top 31.3%.
Is Altrova Health's Tariff Resilience Score too high?
Altrova Health's current Tariff Resilience Score is 5. Based on the distribution chart, Altrova Health ranks #530 out of 1694 companies in the Asset Management industry, which is above the industry midpoint.
How does Altrova Health's Tariff Resilience Score compare to BLK and BX?
According to the Asset Management industry distribution chart, Altrova Health ranks #530 out of 1694 companies for Tariff Resilience Score. This puts Altrova Health in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for an Asset Management company?
A good Tariff Resilience Score depends on the Asset Management industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Altrova Health's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Altrova Health stock overvalued right now?
Altrova Health (FRA:WF8) has a current Tariff Resilience Score of 5. The current Tariff Resilience Score is 5. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Altrova Health (FRA:WF8), the current Tariff Resilience Score is 5 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Altrova Health Business Description

Other Exchanges SSPLF:USAROVA:Canada
Address 666 Burrard Street, 25th Floor, Vancouver, BC, CAN, V6C 2X8
Altrova Health Inc is a Canadian public company building a growing portfolio of health solutions across detection, protection, treatment, and wellness. The Company is focused on supporting multiple products, brands, and growth pathways under one stronger corporate identity, expanding beyond any single product story to create a more durable business. The Company continues to evaluate opportunities to expand its product offerings across the public health and safety sector.